1096-8652/asset/cover.gif?v=1&s=d31a603f9c7a1894ee3b68044c6fdcbe64ff8068 "American Journal of Hematology")
Conflict of interest: Nothing to report.
1096-8652/asset/olbannerleft.gif?v=1&s=d9288d4b31f0b8e9a1eb2d195cb165e0aa1d7a97)
1096-8652/asset/olbannerright.gif?v=1&s=78488ac502104a3d829e729353def6ce62dc1e29)
Research Article
You have full text access to this OnlineOpen article
Genetic modifiers of the severity of sickle cell anemia identified through a genome-wide association study†
Article first published online: 23 OCT 2009
DOI: 10.1002/ajh.21572
Copyright © 2009 Wiley-Liss, Inc.
Additional Information
How to Cite
Sebastiani, P., Solovieff, N., Hartley, S. W., Milton, J. N., Riva, A., Dworkis, D. A., Melista, E., Klings, E. S., Garrett, M. E., Telen, M. J., Ashley-Koch, A., Baldwin, C. T. and Steinberg, M. H. (2010), Genetic modifiers of the severity of sickle cell anemia identified through a genome-wide association study. Am. J. Hematol., 85: 29–35. doi: 10.1002/ajh.21572
- †
Publication History
- Issue published online: 22 DEC 2009
- Article first published online: 23 OCT 2009
- Accepted manuscript online: 23 OCT 2009 12:00AM EST
- Manuscript Accepted: 15 OCT 2009
- Manuscript Received: 14 OCT 2009
Funded by
- NIH/NHLBI. Grant Numbers: R01 HL87681, R01 HL 068970
- Abstract
- References
- Supporting Information
- Cited By
References
- 1,,. Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev 2007; 21: 37–47.
- 2,,. Elderly survivors with homozygous sickle cell disease. N Engl J Med 2007; 356: 642–643.
- 3,,, et al. Chronic hyper-hemolysis in sickle cell anemia: Association of vascular complications and mortality with less frequent vasoocclusive pain. PLoS ONE 2008; 3: e2095.
- 4,,, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994; 330: 1639–1644.
- 5,,, et al. A network model to predict the risk of death in sickle cell disease. Blood 2007; 110: 2727–2735.
- 6,. The cooperative study of sickle cell disease: Review of study design and objectives. Am J Pediatr Hematol Oncol 1982; 4: 197–201.
- 7,,. Usefulness and limitations of Bayesian network model as a mortality risk assessment tool in sickle cell anemia. Am J Hematol 2009; 84: 312–313.
- 8,,, et al. A repertoire of genes modifying the risk of death in sickle cell anemia. Blood (ASH Annu Meeting Abstracts) 2007; 110: 150.
- 9,. How to interpret a genome-wide association study. JAMA 2008; 299: 1335–1344.
- 10. Progress and challenges in genome-wide association studies in humans. Nature 2008; 456: 728–731.
- 11,,,. Laboratory profile of sickle cell disease: A cross-sectional analysis. The Cooperative Study of Sickle Cell Disease. J Clin Epidemiol 1992; 45: 893–909.
- 12,,, et al. Identification of genetic polymorphisms associated with risk for pulmonary hypertension in sickle cell disease. Blood 2008; 111: 5721–5726.
- 13. Pulmonary hypertension of sickle cell disease: More than just another lung disease. Am J Hematol 2008; 83: 4–5.
- 14,,, et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559–575.
- 15,,, et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38: 904–909.
- 16. A tutorial on statistical methods for population association studies. Nat Rev Genet 2006; 7: 781–791.
- 17,,, et al. A hierarchical and modular approach to the discovery of robust associations in genome-wide association studies from pooled DNA samples. BMC Genet 2008; 9: 6.
- 18,,, et al. Genome-wide association studies and the genetic dissection of complex traits. Am J Hematol 2009; 84: 504–515.
- 19,,, et al. Identifying biological themes within lists of genes with EASE. Genome Biol 2003; 4: R70.
- 20,,. Population structure and eigenanalysis. PLoS Genet 2006; 2: e190.
- 21,,, et al. 3rd Annual Sickle Disease Research and Educational Symposium and Annual National Sickle Cell Disease Scientific Meeting, Ft Lauderdale. Am J Hematol 2009;84:E1–E235.Direct Link:
- 22. Genetic etiologies for phenotypic diversity in sickle cell anemia. ScientificWorldJournal 2009; 9: 46–67.
- 23,,, et al. Distinct HLA associations by stroke subtype in children with sickle cell anemia. Blood 2003; 101: 2865–2869.
- 24,,, et al. Gene interactions and stroke risk in children with sickle cell anemia. Blood 2004; 103: 2391–2396.
- 25,,, et al. Association of klotho, bone morphogenic protein 6, and annexin A2 polymorphisms with sickle cell osteonecrosis. Blood 2005; 106: 372–375.
- 26,,, et al. Association of single nucleotide polymorphisms in klotho with priapism in sickle cell anaemia. Br J Haematol 2005; 128: 266–272.
- 27,,, et al. Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia. Nat Genet 2005; 37: 435–440.
- 28,,, et al. Sickle cell leg ulcers: Associations with haemolysis and SNPs in klotho, TEK and genes of the TGF-β/BMP pathway. Br J Haematol 2006; 133: 570–578.
- 29,,, et al. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia. Proc Natl Acad Sci USA 2008; 105: 1620–1625.
- 30,,, et al. BCL11A is a major HbF quantitative trait locus in three different populations with beta-hemoglobinopathies. Blood Cells Mol Dis 2008; 41: 255–258.
- 31,,, et al. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc Natl Acad Sci USA 2008; 105: 11869–11874.
- 32,,, et al. Differential gene expression in pulmonary artery endothelial cells exposed to sickle cell plasma. Physiol Genomics 2005; 21: 293–298.
- 33,,. The endothelial biology of sickle cell disease: Inflammation and a chronic vasculopathy. Microcirculation 2004; 11: 129–151.
- 34. Red cell membrane in sickle cell disease. In: SteinbergMH, ForgetBG, HiggsDR, NagelRL, editors. Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management. Cambridge: Cambridge University Press; 2001. pp 550–576.
- 35,,, et al. Divergent and convergent effects on gene expression and function in acute versus chronic endothelial activation. Physiol Genomics 2007; 31: 104–113.
- 36,,, et al. The human reticulocyte transcriptome. Physiol Genomics 2007; 30: 172–178.
- 37,. The role of the poly(ADP-ribose) polymerase tankyrase1 in telomere length control by the TRF1 component of the shelterin complex. J Biol Chem 2007; 282: 22662–22667.
- 38. Vascular endothelial senescence: From mechanisms to pathophysiology. J Appl Physiol 2009; 106: 326–332.
- 39,. Mechanisms of endothelial senescence. Exp Physiol 2009; 94: 299–304.
- 40,,,. Therapeutic doses of hydroxyurea cause telomere dysfunction and reduce TRF2 binding to telomeres. Cancer Biol Ther 2009; 8: 1136–1145.
- 41,,, et al. Mixed lineage kinase LZK forms a functional signaling complex with JIP-1, a scaffold protein of the c-Jun NH(2)-terminal kinase pathway. J Biochem 2001; 130: 773–781.
- 42,. Role of the human C8 subunits in complement-mediated bacterial killing: Evidence that C8 gamma is not essential. Mol Immunol 2002; 39: 453–458.
- 43. The membrane attack complex of complement. Assembly, structure and cytotoxic activity. Toxicology 1994; 87: 229–247.